Irrespectively, our results show that cancer and/or stromal cells-derived factors like TGF-β1 and BMP2 have the capacity to modulate Runx2 expression in pancreatic cancer and stellate cells in an autocrine/paracrine fashion. This evidence concerns the gene TGFB1 and pancreatic neoplasm.